Spike Rbd Sequence

Rabbit monoclonal Anti-MERS Spike protein (S1/RBD/MERS-RBD) IgG (Neutralizing)

MERS122-M 100 ul
EUR 781.2

Human IgG antibody Laboratories manufactures the spike rbd sequence reagents distributed by Genprice. The Spike Rbd Sequence reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Spike RBD. Other Spike products are available in stock. Specificity: Spike Category: Rbd Group: Sequence

True north Cryobox 5mLBlue

PK10
EUR 153.6

True north Cryobox 15mLNatural

PK10
EUR 212.4

True north Cryobox 15mLBlue

PK10
EUR 212.4

True north Cryobox 50mLNatural

PK10
EUR 210

True north Cryobox 50mLBlue

PK10
EUR 210

True north Cryobox1.5/2mLNatural

PK10
EUR 162

True north Cryobox1.5/2.0mLGreen

PK10
EUR 162

Sequence information

Spike S1 RBD, Fc fusion (SARS-CoV-2)

100699-2 100 µg
EUR 520
Description: SARS-CoV-2 2019-nCoV Spike protein S1 subunit, receptor binding domain (RBD), also known as SARS-CoV-2 spike RBD, novel coronavirus spike RBD and nCoV spike RBD, GenBank Accession No. QHD43416.1, a.a. 319-541, with C-terminal Fc-tag, expressed in a CHO cell expression system. MW=50 kDa. This protein runs at a higher MW by SDS-PAGE due to glycosylation.

Erythropoietin Mimetic Peptide Sequence 20

H-4344.0001 1.0mg
EUR 544.8
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net

Erythropoietin Mimetic Peptide Sequence 20

H-4344.0005 5.0mg
EUR 2067.6
Description: Sum Formula: C72H99N17O17S2; CAS# [203397-62-0] net

Anti-Signal sequence receptor delta (2D3)

YF-MA15624 100 ug
EUR 435.6
Description: Mouse monoclonal to Signal sequence receptor delta

TPA-Induced Sequence 11b (TIS11B) Antibody

20-abx219410
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

G-Rich Sequence Factor 1 (GRSF1) Antibody

abx340117-100ug 100 ug
EUR 469.2

Signal Sequence Receptor Delta (SSR4) Antibody

20-abx137478
  • EUR 844.80
  • EUR 393.60
  • EUR 276.00
  • 100 ug
  • 20 ug
  • 5 ug

Signal Sequence Receptor Alpha (SSRa) Antibody

20-abx131611
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Neuroblastoma Amplified Sequence (NBAS) Antibody

abx235565-100ug 100 ug
EUR 610.8

Neuroblastoma Amplified Sequence (NBAS) Antibody

20-abx217051
  • EUR 510.00
  • EUR 410.40
  • 100 ug
  • 50 ug

Neuroblastoma Amplified Sequence (NBAS) Antibody

20-abx321319
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Neuroblastoma Amplified Sequence (NBAS) Antibody

20-abx114066
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Neuroblastoma Amplified Sequence (NBAS) Antibody

20-abx003586
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Glioblastoma-Amplified Sequence (GBAS) Antibody

abx146091-100ug 100 ug
EUR 469.2

Glioblastoma-Amplified Sequence (GBAS) Antibody

abx032970-400ul 400 ul
EUR 627.6

Glioblastoma-Amplified Sequence (GBAS) Antibody

abx032970-80l 80 µl
EUR 343.2

SARS-CoV-2 (COVID-19) Spike RBD Antibody

9087-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a Spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Coronavirus invades cells through Spike (S) glycoproteins, a class I fusion protein. It is the major viral surface protein that coronavirus uses to bind to the human cell surface receptor. It also mediates the fusion of host and viral cell membrane, allowing the virus to enter human cells and begin infection (3). The spike protein is the major target for neutralizing antibodies and vaccine development (4). The protein modeling suggests that there is strong interaction between Spike protein receptor-binding domain and its host receptor angiotensin-converting enzyme 2 (ACE2), which regulate both the cross-species and human-to-human transmissions of COVID-19 (5). The recent study has shown that the SARS-CoV-2 spike protein binds ACE2 with higher affinity than SARS-CoV spike protein (6).